FeesSafety
Pluang+

Twenty One Capital buys 154.32 BTC for $10M, raising holdings to about 43,670 BTC.

Market News
16 Nov 2026, 23:39 WIB
Tokenpost
View Source
Bullish
Twenty One Capital buys 154.32 BTC for $10M, raising holdings to about 43,670 BTC.

Twenty One Capital purchased 154.32 Bitcoin for approximately $10 million, averaging $64,801 per coin. This acquisition increased their total Bitcoin holdings to around 43,670 BTC. The company had reported a balance of 43,514 BTC as of September 30 in its Q3 results. This move signals continued confidence in Bitcoin as a digital asset investment.

Twenty One Capital's recent Bitcoin purchase provides context for cryptocurrency market activity. For readers following major cryptocurrencies on Pluang, 27 of 50 priced assets rose while 21 fell as of Nov 17, 2026 04:43 WIB. Notable movers include FTM at Rp11,382 with a 2.05% decline, NEO at Rp29,291 with a 1.86% increase and a 53% buy order activity, and CRV at Rp3,734 with a 1.77% rise and 90% buy order activity.

More News

Disney Q4 outlook strong with 50%+ EPS growth and streaming as key driver

Disney Q4 outlook strong with 50%+ EPS growth and streaming as key driver

Disney's fiscal Q4 report, due November 17, is expected to show strong growth with analysts forecasting over 50% earnings per share (EPS) growth and more than 12% revenue increase. Streaming revenue rose 11% last quarter with margins hitting double d...

Company Fundamentals
Bullish
3 hours ago
Infoblox launches Australia realm on AWS for local DDI management and security.

Infoblox launches Australia realm on AWS for local DDI management and security.

Infoblox has launched a new Australia realm on Amazon Web Services (AWS) in the Sydney region, providing Australian government agencies and enterprises a local option for managing DNS, DHCP, and IP address management (DDI) with enhanced security. Thi...

Market News
Bullish
3 hours ago
European Commission approves RASONQUE for metastatic pancreatic cancer treatment

European Commission approves RASONQUE for metastatic pancreatic cancer treatment

The European Commission has approved RASONQUE (daraxonrasib), the first broad RAS-targeted oral medicine for adults with metastatic pancreatic adenocarcinoma who have had prior systemic therapy. This approval covers patients with or without identifie...

Market News
Bullish
4 hours ago
SPIE acquires Duflex to boost industrial automation and robotics in the Netherlands.

SPIE acquires Duflex to boost industrial automation and robotics in the Netherlands.

SPIE, a European leader in multi-technical services, has acquired Dutch company Duflex B.V. to enhance its industrial automation, machine building, and robotics capabilities. Duflex, with 26 employees and €8 million revenue in 2025, specializes in ta...

Company Fundamentals
Bullish
5 hours ago
Rexel repurchases 3,878 own shares at an average price of €34.67 from Nov 9-13, 2026

Rexel repurchases 3,878 own shares at an average price of €34.67 from Nov 9-13, 2026

Rexel Développement SAS disclosed that it repurchased a total of 3,878 of its own shares between November 9 and November 13, 2026. The average purchase price during this period was approximately €34.67 per share. This buyback is part of an authorized...

Company Fundamentals
Neutral
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App